Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MABTHERA for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 39 adverse event reports in the FDA FAERS database where MABTHERA was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for MABTHERA

Side Effect Reports % Deaths Hosp.
Death 71 11.3% 71 3
Pyrexia 37 5.9% 5 24
Pain 25 4.0% 4 17
Progressive multifocal leukoencephalopathy 25 4.0% 6 10
Dyspnoea 23 3.7% 4 14
Vomiting 23 3.7% 1 22
Arthralgia 22 3.5% 0 17
Drug ineffective 22 3.5% 2 12
Infection 20 3.2% 1 15
Malaise 20 3.2% 0 12
Diarrhoea 19 3.0% 3 14
Headache 18 2.9% 2 15
Neutropenia 18 2.9% 2 9
Pain in extremity 18 2.9% 0 11
Pneumonia 18 2.9% 5 11

Other Indications for MABTHERA

Rheumatoid arthritis (169) Non-hodgkin's lymphoma (100) Product used for unknown indication (66) B-cell lymphoma (52) Chronic lymphocytic leukaemia (44) Lymphoma (27) Mantle cell lymphoma (16) Systemic lupus erythematosus (11) Non-hodgkin's lymphoma unspecified histology aggressive (9) Burkitt's lymphoma (8)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

MABTHERA Full Profile All Diffuse large b-cell lymphoma Drugs MABTHERA Demographics MABTHERA Timeline